The distinction between device clearance and drug approval is significant, and the press release allegedly caused a stock price increase based on investor misunderstanding of the regulatory status
doi: 10.1016/S2213-8587(22)00340-0 Retrieved from De Block, C., Bailey, C., & Wysham, C
The market is also likely to expand well beyond weight loss, given the many medical conditions that GLP-1 drugs are being tested against
Do not take Wegovy if you have: A personal or family history of medullary thyroid carcinoma (MTC) a specific type of thyroid cancer A condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) A known allergy to semaglutide or any ingredient in Wegovy Talk to your licensed healthcare provider first if you have a history of: Pancreatitis Gallbladder problems Kidney issues Eating disorders Severe gastrointestinal disease Depression or thoughts of self-harm The Wegovy Pen may also not be the right practical fit if: Cost is a significant barrier
Safe, medical-grade formulations provided under supervision
For people who do take Trulicity, it is important to be alert to the signs and symptoms of thyroid cancer and contact a healthcare provider immediately if there is a lump in the neck, hoarseness, or difficulty breathing or swallowing
